Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Recs

0
Player Avatar getrichdietrying (82.25) Submitted: 6/12/2013 10:45:08 PM : Underperform Start Price: $3.99 SVA Score: -46.70

ChinaRTO

Featured Broker Partners


Advertisement